Saltar al contenido principal

ETHNOS_APP

Inicio • Búsqueda • Revistas • Lista 0

Where Is the Opioid Use Epidemic in Mexico? A Cautionary Tale for Policymakers South of the US–Mexico Border

Datos Bibliográficos

ID11022501
AutoresDavid Goodman-Meza (0000-0001-9382-3564, David Goodman-Meza and Raphael J. Landovitz are with Division of Infectious Diseases, David Geffen School of Medicine at University of California Los Angeles (UCLA). Raphael J. Landovitz is also with Center for Clinical AIDS Research and Education, Los Angeles. Maria Elena Medina-Mora is with Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz, Mexico City, Mexico. Carlos Magis-Rodríguez is with National Center for the Prevention and Control of HIV and AIDS, Mexico City. Steve Shoptaw is with...), Maria Elena Medina-Mora (0000-0001-9300-0752, David Goodman-Meza and Raphael J. Landovitz are with Division of Infectious Diseases, David Geffen School of Medicine at University of California Los Angeles (UCLA). Raphael J. Landovitz is also with Center for Clinical AIDS Research and Education, Los Angeles. Maria Elena Medina-Mora is with Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz, Mexico City, Mexico. Carlos Magis-Rodríguez is with National Center for the Prevention and Control of HIV and AIDS, Mexico City. Steve Shoptaw is with...), Carlos Magis-Rodriguez (David Goodman-Meza and Raphael J. Landovitz are with Division of Infectious Diseases, David Geffen School of Medicine at University of California Los Angeles (UCLA). Raphael J. Landovitz is also with Center for Clinical AIDS Research and Education, Los Angeles. Maria Elena Medina-Mora is with Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz, Mexico City, Mexico. Carlos Magis-Rodríguez is with National Center for the Prevention and Control of HIV and AIDS, Mexico City. Steve Shoptaw is with...), Carlos Magis‐Rodríguez (0000-0001-5481-1253, Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz), Raphael J Landovitz (0000-0002-1442-714X, David Goodman-Meza and Raphael J. Landovitz are with Division of Infectious Diseases, David Geffen School of Medicine at University of California Los Angeles (UCLA). Raphael J. Landovitz is also with Center for Clinical AIDS Research and Education, Los Angeles. Maria Elena Medina-Mora is with Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz, Mexico City, Mexico. Carlos Magis-Rodríguez is with National Center for the Prevention and Control of HIV and AIDS, Mexico City. Steve Shoptaw is with...), Steven Shoptaw (0000-0002-3583-0026, Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz), Steve Shoptaw (David Goodman-Meza and Raphael J. Landovitz are with Division of Infectious Diseases, David Geffen School of Medicine at University of California Los Angeles (UCLA). Raphael J. Landovitz is also with Center for Clinical AIDS Research and Education, Los Angeles. Maria Elena Medina-Mora is with Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz, Mexico City, Mexico. Carlos Magis-Rodríguez is with National Center for the Prevention and Control of HIV and AIDS, Mexico City. Steve Shoptaw is with...), Dan Werb (0000-0003-0614-9386, David Goodman-Meza and Raphael J. Landovitz are with Division of Infectious Diseases, David Geffen School of Medicine at University of California Los Angeles (UCLA). Raphael J. Landovitz is also with Center for Clinical AIDS Research and Education, Los Angeles. Maria Elena Medina-Mora is with Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz, Mexico City, Mexico. Carlos Magis-Rodríguez is with National Center for the Prevention and Control of HIV and AIDS, Mexico City. Steve Shoptaw is with...)
Año2019
Volumen109
Número1
Páginas73-82
Fecha de publicación2019-01-01
Peer ReviewedSí
Open AccessNo
TipoARTICLE
RevistaAmerican Journal of Public Health (JOURNAL)
Identificadores de la revistaISSN: 0090-0036 • E-ISSN: 1541-0048
EditorialAmerican Public Health Association (PUBLISHER • US)
DOI10.2105/ajph.2018.304767
PMID30495992
OpenAlexW2903417556
IdiomaEN
Citas recibidas8
Referencias citadas73

In North America, opioid use and its harms have increased in the United States and Canada over the past 2 decades. However, Mexico has yet to document patterns suggesting a higher level of opioid use or attendant harms. Historically, Mexico has been a country with low-level use of opioids, although heroin use has been documented. Low-level opioid use is likely attributable to structural, cultural, and individual factors. However, a range of dynamic factors may be converging to increase the use of opioids: legislative changes to opioid prescribing, national health insurance coverage of opioids, pressure from the pharmaceutical industry, changing demographics and disease burden, forced migration and its trauma, and an increase in the production and trafficking of heroin. In addition, harm-reduction services are scarce. Mexico may transition from a country of low opioid use to high opioid use but has the opportunity to respond effectively through a combination of targeted public health surveillance of high-risk groups, preparation of appropriate infrastructure to support evidence-based treatment, and interventions and policies to avoid a widespread opioid use epidemic

Drug · Environmental health · Geography · Harm · Harm reduction · Heroin · Legislature · Opioid · Opioid use disorder · Political science · Psychiatry · Psychological intervention · Public health · HIV, Drug Use, Sexual Risk · Medicine · Opioid Use Disorder Treatment · Substance Abuse Treatment and Outcomes

  • Examining the gender composition of drug injecting initiation events

    Open Access•Meyers SA, Claudia Rafful et al.•International Journal of Drug…•2021

  • Responding to the opioid crisis in North America and beyond

    Open Access•Keith Humphreys, Chelsea L Shover et al.•The Lancet•2022

  • Exploring potential underestimates in fatal overdose mortality across major metropolitan areas in Mexico between 2005 and 2019

    Open Access•Raúl Bejarano-Romero, Jaime Arredondo Sánchez Lira et al.•BMC Public Health•2025

  • Risk of non‐fatal overdose and polysubstance use in a longitudinal study with people who inject drugs in Tijuana, Mexico

    Open Access•Carlos D Rivera Saldana, Daniela Abramovitz et al.•Drug and Alcohol Review•2021

  • Sex differences in the multilevel determinants of injection risk behaviours among people who inject drugs in Tijuana, Mexico

    Open Access•Jennifer Jain, Steffanie A Strathdee et al.•Drug and Alcohol Review•2020

  • Investigating a bidirectional relationship between overdose and provision of injection initiation assistance among persons who inject drugs in Vancouver, Canada and Tijuana, Mexico

    Open Access•Jeanette M Bowles, Sonia Jain et al.•International Journal of Drug…•2021

  • The introduction of fentanyl on the US–Mexico border

    Open Access•Joseph Friedman, P Bourgois et al.•International Journal of Drug…•2022

  • Spatial Heterogeneity in Fatal Overdose Rate Trends in Mexican Cities

    Rosie Mae Henson, Pricila H Mullachery et al.•American Journal of Public Health•2024

  • Making sense of implementation theories, models and frameworks

    Open Access•Phoebe Nilsen, Per Nilsen•Implementation Science•2015

  • Alleviating the access abyss in palliative care and pain relief—an imperative of universal health coverage

    Open Access•Felicia M Knaul, Paul E Farmer et al.•The Lancet•2018

  • Historical trends in the production and consumption of illicit drugs in Mexico

    Open Access•Jesus Bucardo, Kimberly C Brouwer et al.•Drug and Alcohol Dependence•2005

  • Mexico's Evolving HIV Epidemic

    Steffanie A Strathdee•JAMA•2008

  • Increases in Drug and Opioid Overdose Deaths — United States, 2000–2014

    Open Access•Rose A Rudd, Noah Aleshire et al.•MMWR. Surveillance Summaries•2016

  • Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015

    Christina Fitzmaurice, Global Burden of Disease Cancer Collaboration et al.•JAMA Oncology•2017

  • Epidemiology of Substance Use among Forced Migrants

    Open Access•Danielle Horyniak, Jason S Melo et al.•PLoS ONE•2016

  • Deportation Along the U.S.–Mexico Border

    Open Access•Kimberly C Brouwer, Remedios Lozada et al.•Journal of Immigrant and Minority…•2008

  • Common Mental Disorders at the Time of Deportation

    Open Access•Ietza Bojorquez, Rosa María Aguilera et al.•Journal of Immigrant and Minority…•2014

  • Opioid analgesics and heroin

    Open Access•Grant Victor, Grant A Victor et al.•International Journal of Drug…•2017

  • Negotiating access

    Open Access•Peter J Davidson, Remedios Lozada et al.•International Journal of Drug…•2012

  • Prescription opioid misuse in the United States and the United Kingdom

    Open Access•Daniel F Weisberg, Wesley C Becker et al.•International Journal of Drug…•2014

  • Mexico's drug policy reform

    Open Access•Dan Werb, María Elena Medina Mora et al.•International Journal of Drug…•2014

  • Health-damaging policing practices among persons who inject drugs in Mexico

    Open Access•Miguel Pinedo, Leo Beletsky et al.•International Journal of Drug…•2017

  • The Textures of Heroin

    Sarah G Mar, P Bourgois et al.•Journal of Psychoactive Drugs•2016

  • A Qualitative View of Drug Use Behaviors of Mexican Male Injection Drug Users Deported from the United States

    Open Access•Victoria D Ojeda, Angela M Robertson et al.•Journal of Urban Health•2011

  • Anomic depression and the migrating family

    Open Access•James E Lantz, James Lantz et al.•Contemporary Family Therapy•1990

  • U.S. immigration policy and family separation

    Open Access•J Dreby•Social Science & Medicine•2014

  • Attempts to Undermine Tobacco Control

    Ernesto M Sebrié, Stanton A Glantz•American Journal of Public Health•2007

  • The Promotion and Marketing of OxyContin

    Art Van Zee•American Journal of Public Health•2009

  • Deported Mexican migrants

    Open Access•Julián Alfredo Fernández-Niño, Carlos Jacobo Ramírez-Valdés et al.•Revista de Saúde Pública•2014

Obras citantes distintas8
Citas por año1,33
Intervalo de citas2020 - 2025 (6)
Velocidad de citaciónrecent
Altamente citadoNo
Tipos de citaNeutras: 7
Ethnos_APP • Proyecto Open Source • Licencia MIT • Frontend v2.0.0 • Privacidad y Cookies • Documentación de la API: api.ethnos.app/docs • Código de la API: GitHub • DOI: 10.5281/zenodo.17049435 • Código del Frontend: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae